Enhanced antigenicity leads to altered immunogenicity in sulfamethoxazole-hypersensitive patients with cystic fibrosis.
Elsheikh A, Castrejon L, Lavergne SN, Whitaker P, Monshi M, Callan H, El-Ghaiesh S, Farrell J, Pichler WJ, Peckham D, Park BK, Naisbitt DJ.
Elsheikh A, et al. Among authors: lavergne sn.
J Allergy Clin Immunol. 2011 Jun;127(6):1543-51.e3. doi: 10.1016/j.jaci.2010.12.1119. Epub 2011 Feb 26.
J Allergy Clin Immunol. 2011.
PMID: 21354601